Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.73 AUD | -1.33% | +2.62% | -16.98% |
May. 09 | Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million | MT |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.98% | 1.79B | |
+37.46% | 705B | |
+32.62% | 583B | |
-3.08% | 364B | |
+20.31% | 332B | |
+5.67% | 291B | |
+16.83% | 238B | |
-3.48% | 210B | |
+10.46% | 209B | |
+9.37% | 169B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Limited Appoints Jon Pilcher as Managing Director